-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Viracta Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Viracta Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$10.2M, a 18.4% increase year-over-year.
- Viracta Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$47.2M, a 3.07% increase year-over-year.
- Viracta Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$50.7M, a 0.21% decline from 2022.
- Viracta Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$50.6M, a 55.7% increase from 2021.
- Viracta Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$114M, a 507% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)